Cargando…

A Longitudinal Study of Plasma pTau181 in Mild Cognitive Impairment with Lewy Bodies and Alzheimer's Disease

BACKGROUND: Alzheimer's disease (AD) co‐pathology is common in dementia with Lewy bodies and is associated with increased decline. Plasma pTau181 is a blood‐based biomarker that can detect AD co‐pathology. OBJECTIVES: We investigated whether pTau181 was associated with cognitive decline in mild...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomas, Alan J., Hamilton, Calum A., Heslegrave, Amanda, Barker, Sally, Durcan, Rory, Lawley, Sarah, Barnett, Nicola, Lett, Debbie, Firbank, Michael, Roberts, Gemma, Taylor, John‐Paul, Donaghy, Paul C., Zetterberg, Henrik, O'Brien, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Regular Issue Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540809/ https://www.ncbi.nlm.nih.gov/pubmed/35318733 http://dx.doi.org/10.1002/mds.28994

Ejemplares similares

Functional connectivity in mild cognitive impairment with Lewy bodies
por: Schumacher, Julia, et al.
Publicado: (2021)

Mild cognitive impairment with Lewy bodies: blood perfusion with arterial spin labelling
por: Firbank, Michael J., et al.
Publicado: (2020)

Assessment of autonomic symptoms may assist with early identification of mild cognitive impairment with Lewy bodies
por: Hamilton, Calum A., et al.
Publicado: (2022)

Blood pressure and heart rate responses to orthostatic challenge and Valsalva manoeuvre in mild cognitive impairment with Lewy bodies
por: Hamilton, Calum A., et al.
Publicado: (2022)

Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer’s disease
por: Schumacher, Julia, et al.
Publicado: (2021)

Accuracy of Cardiac Innervation Scintigraphy for Mild Cognitive Impairment With Lewy Bodies
por: Roberts, Gemma, et al.
Publicado: (2021)

Comparing tau status determined via plasma pTau181, pTau231 and [(18)F]MK6240 tau-PET
por: Tissot, Cécile, et al.
Publicado: (2022)

Quantitative EEG as a biomarker in mild cognitive impairment with Lewy bodies
por: Schumacher, Julia, et al.
Publicado: (2020)

In vivo nucleus basalis of Meynert degeneration in mild cognitive impairment with Lewy bodies
por: Schumacher, Julia, et al.
Publicado: (2021)

Progression to Dementia in Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease
por: Hamilton, Calum A., et al.
Publicado: (2021)

Plasma pTau181 as a biomarker for Alzheimer's disease
por: Meng, Jie, et al.
Publicado: (2020)

Plasma pTau181 predicts cortical brain atrophy in aging and Alzheimer’s disease
por: Tissot, Cécile, et al.
Publicado: (2021)

Microbleeds in dementia with Lewy bodies
por: Donaghy, Paul C., et al.
Publicado: (2020)

A Head-to-Head Comparison Between Plasma pTau181 and Tau PET Along the Alzheimer’s Disease Continuum
por: Coomans, Emma M., et al.
Publicado: (2023)

Clinical and imaging correlates of amyloid deposition in dementia with Lewy bodies
por: Donaghy, Paul C., et al.
Publicado: (2018)

EEG alpha reactivity and cholinergic system integrity in Lewy body dementia and Alzheimer’s disease
por: Schumacher, Julia, et al.
Publicado: (2020)

Amyloid-β levels and cognitive trajectories in non-demented pTau181-positive subjects without amyloidopathy
por: Oberstein, Timo Jan, et al.
Publicado: (2022)

Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer’s Disease
por: Meredith Jr., Jere E., et al.
Publicado: (2013)

Cortical microstructural associations with CSF amyloid and pTau
por: Nir, Talia M., et al.
Publicado: (2023)

High altitude is associated with pTau deposition, neuroinflammation, and myelin loss
por: Iacono, Diego, et al.
Publicado: (2022)

Visual cortical excitability in dementia with Lewy bodies
por: Taylor, John-Paul, et al.
Publicado: (2016)

Can early phase cardiac [(123)I]mIBG images be used to diagnose Lewy body disease?
por: Roberts, Gemma, et al.
Publicado: (2022)

Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
por: Fagan, Anne M, et al.
Publicado: (2009)

Long reaction times are associated with delayed brain activity in lewy body dementia
por: Firbank, Michael J., et al.
Publicado: (2017)

Diagnostic accuracy of dopaminergic imaging in prodromal dementia with Lewy bodies
por: Thomas, Alan J., et al.
Publicado: (2019)

Peripheral inflammation in prodromal Alzheimer’s and Lewy body dementias
por: King, Eleanor, et al.
Publicado: (2018)

Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer’s Disease
por: Lilek, Jaclyn, et al.
Publicado: (2023)

Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer’s disease, frontotemporal dementia and progressive supranuclear palsy
por: Chouliaras, Leonidas, et al.
Publicado: (2022)

Diagnostic accuracy of the plasma ALZpath pTau217 immunoassay to identify Alzheimer’s disease pathology
por: Ashton, Nicholas J., et al.
Publicado: (2023)

Semantic intrusion errors are associated with plasma Ptau-181 among persons with amnestic mild cognitive impairment who are amyloid positive
por: Curiel Cid, Rosie E., et al.
Publicado: (2023)

Potential association between frailty and pTau in community-dwelling older adults
por: Zhou, Lixing, et al.
Publicado: (2022)

Visual hallucinations in dementia with Lewy bodies: transcranial magnetic stimulation study
por: Taylor, John-Paul, et al.
Publicado: (2011)

Impaired sensory evidence accumulation and network function in Lewy body dementia
por: O’Callaghan, Claire, et al.
Publicado: (2021)

Visual cortex in dementia with Lewy bodies: magnetic resonance imaging study
por: Taylor, John-Paul, et al.
Publicado: (2012)

Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease
por: Batzu, Lucia, et al.
Publicado: (2022)

A new visual rating scale for Ioflupane imaging in Lewy body disease
por: Lloyd, Jim J., et al.
Publicado: (2018)

The challenges of COVID‐19 for people with dementia with Lewy bodies and family caregivers
por: Killen, Alison, et al.
Publicado: (2020)

Reduction of pTau and APP levels in mammalian brain after low-dose radiation
por: Iacono, Diego, et al.
Publicado: (2021)

Functional connectivity of the nucleus basalis of Meynert in Lewy body dementia and Alzheimer’s disease
por: Schumacher, Julia, et al.
Publicado: (2021)

The Expression of Cellular Prion Protein, PrPC, Favors pTau Propagation and Blocks NMDAR Signaling in Primary Cortical Neurons
por: Rivas-Santisteban, Rafael, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p7kiqlm3s1fl6pftl0lm3d5u7n